Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clazosentan for prevention of cerebral vasospasm after aneurysmal subarachnoid hemorrhage clipping
jRCT2080222837Phase 2Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Apr 2015
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in subarachnoid hemorrhage (SAH) and cerebral vasospasm comparing Clazosentan with Placebo (2 arms). Started Apr 2015; status: completed.
02
Drugs
clazosentan
03
Conditions
subarachnoid hemorrhage (SAH)cerebral vasospasm
Beyond the preview
Go deeper on jRCT2080222837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222837.